A Study to Evaluate the Effect of MK-5684 in Male Participants With Severe Renal Impairment (RI) and With End-stage Renal Disease (ESRD) (MK-5684-010)

NCT06814132 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Failure, Chronic
End-Stage Kidney Disease
Renal Failure, Chronic
Renal Failure, End-Stage
Healthy Participants

Interventions

DRUG: MK-5684
DRUG: Prednisone
DRUG: Fludrocortisone acetate

Sponsor

Merck Sharp & Dohme LLC